BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 37543235)

  • 1. A Dosimetric Correlation Between Radiation Dose to Bone and Reduction of Hemoglobin Levels After Radiation Therapy for Prostate Cancer.
    Fenlon JB; Nelson G; Teague KM; Coleman S; Shrieve D; Tward J
    Int J Radiat Oncol Biol Phys; 2024 Jan; 118(1):85-93. PubMed ID: 37543235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of neoadjuvant hormonal therapy on dose-volume histograms in patients with localized prostate cancer under radical radiation therapy.
    Samper PM; López Carrizosa MC; Pérez Casas A; Vallejo C; Rubio Rodríguez MC; Pérez Vara C; Melchor Iñiguez M
    Clin Transl Oncol; 2006 Aug; 8(8):599-605. PubMed ID: 16952849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate seed implantation using 3D-computer assisted intraoperative planning vs. a standard look-up nomogram: Improved target conformality with reduction in urethral and rectal wall dose.
    Raben A; Chen H; Grebler A; Geltzeiler J; Geltzeiler M; Keselman I; Litvin S; Sim S; Hanlon A; Yang J
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1631-8. PubMed ID: 15590195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical toxicities and dosimetric parameters after whole-pelvis versus prostate-only intensity-modulated radiation therapy for prostate cancer.
    Deville C; Both S; Hwang WT; Tochner Z; Vapiwala N
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):763-72. PubMed ID: 20171807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy.
    Vargas C; Martinez A; Kestin LL; Yan D; Grills I; Brabbins DS; Lockman DM; Liang J; Gustafson GS; Chen PY; Vicini FA; Wong JW
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1297-308. PubMed ID: 16029785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosimetric study of uniform scanning proton therapy planning for prostate cancer patients with a metal hip prosthesis, and comparison with volumetric-modulated arc therapy.
    Rana S; Cheng C; Zheng Y; Hsi W; Zeidan O; Schreuder N; Vargas C; Larson G
    J Appl Clin Med Phys; 2014 May; 15(3):4611. PubMed ID: 24892333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose to bone marrow using IMRT techniques in prostate cancer patients.
    Gershkevitsh E; Clark CH; Staffurth J; Dearnaley DP; Trott KR
    Strahlenther Onkol; 2005 Mar; 181(3):172-8. PubMed ID: 15756521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow doses and leukaemia risk in radiotherapy of prostate cancer.
    Gershkevitsh E; Rosenberg I; Dearnaley DP; Trott KR
    Radiother Oncol; 1999 Dec; 53(3):189-97. PubMed ID: 10660197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of three-dimensional radiation therapy planning tools and intraoperative ultrasound to evaluate high dose rate prostate brachytherapy implants.
    Kini VR; Edmundson GK; Vicini FA; Jaffray DA; Gustafson G; Martinez AA
    Int J Radiat Oncol Biol Phys; 1999 Feb; 43(3):571-8. PubMed ID: 10078639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosimetric advantage and clinical implication of a micro-multileaf collimator in the treatment of prostate with intensity-modulated radiotherapy.
    Wang L; Hoban P; Paskalev K; Yang J; Li J; Chen L; Xiong W; Ma CC
    Med Dosim; 2005; 30(2):97-103. PubMed ID: 15922176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pelvic nodal dose escalation with prostate hypofractionation using conformal avoidance defined (H-CAD) intensity modulated radiation therapy.
    Hong TS; Tomé WA; Jaradat H; Raisbeck BM; Ritter MA
    Acta Oncol; 2006; 45(6):717-27. PubMed ID: 16938815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
    Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
    J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher than standard radiation doses (> or =72 Gy) with or without androgen deprivation in the treatment of localized prostate cancer.
    Kupelian PA; Mohan DS; Lyons J; Klein EA; Reddy CA
    Int J Radiat Oncol Biol Phys; 2000 Feb; 46(3):567-74. PubMed ID: 10701735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of IMRT in reducing penile doses in dose escalation for prostate cancer.
    Sethi A; Mohideen N; Leybovich L; Mulhall J
    Int J Radiat Oncol Biol Phys; 2003 Mar; 55(4):970-8. PubMed ID: 12605975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensity-modulated radiotherapy for soft tissue sarcoma of the thigh.
    Hong L; Alektiar KM; Hunt M; Venkatraman E; Leibel SA
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):752-9. PubMed ID: 15183478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VMAT partial arc technique decreases dose to organs at risk in whole pelvic radiotherapy for prostate cancer when compared to full arc VMAT and IMRT.
    Bartlett GK; Njeh CF; Huang KC; DesRosiers C; Guo G
    Med Dosim; 2023 Spring; 48(1):8-15. PubMed ID: 36319515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pelvic organ motion and dosimetric implications during horizontal patient rotation for prostate radiation therapy.
    Buckley JG; Dowling JA; Sidhom M; Liney GP; Rai R; Metcalfe PE; Holloway LC; Keall PJ
    Med Phys; 2021 Jan; 48(1):397-413. PubMed ID: 33151543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility of spine stereotactic body radiotherapy for patients with large tumors in multiple vertebrae undergoing re-irradiation: Dosimetric challenge using 3 different beam delivery techniques.
    Furuya T; Phua JH; Ito K; Karasawa K
    Med Dosim; 2019 Winter; 44(4):415-420. PubMed ID: 30929978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rectal wall sparing by dosimetric effect of rectal balloon used during intensity-modulated radiation therapy (IMRT) for prostate cancer.
    Teh BS; Dong L; McGary JE; Mai WY; Grant W; Butler EB
    Med Dosim; 2005; 30(1):25-30. PubMed ID: 15749008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensity-modulated radiation therapy for pancreatic and prostate cancer using pulsed low-dose rate delivery techniques.
    Li J; Lang J; Wang P; Kang S; Lin MH; Chen X; Chen F; Guo M; Chen L; Ma CM
    Med Dosim; 2014; 39(4):330-6. PubMed ID: 25087084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.